Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-26 @ 7:43 AM
Study NCT ID:
NCT03370861
Status:
TERMINATED
Last Update Posted:
2024-09-05
First Post:
2017-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
Sponsor:
Washington University School of Medicine
Organization:
Study Overview
Official Title:
Immunotherapy Multi-omics Specimen Protocol A
Status:
TERMINATED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Subject recruitment was limited severely by the 2020-2023 COVID-19 pandemic, which led this study to be closed.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MINING
Brief Summary:
The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.
Detailed Description:
Details will be available upon publication.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: